IVAX Diagnostics, Inc. (AMEX: IVD), a fully integrated global in vitro
diagnostics company, announced that Diamedix Corporation has signed a
distribution agreement with Fumouze Diagnostics, a division of Sofibel
S.A.S., of Paris, France, pursuant to which Fumouze Diagnostics will be
the exclusive third party distributor of Diamedix Corporation and Delta
Biologicals S.r.l.’s suite of diagnostic tests in France. Diamedix is a
U.S. subsidiary of IVAX Diagnostics and Delta Biologicals is IVAX
Diagnostics’ subsidiary located in Italy. The initial term of the
distribution agreement is three years.
Fumouze Diagnostics has been a major participant in the diagnostics
field for more than 40 years, and offers a broad range of products to
its private and public laboratory clients. To support the sales efforts
in France under this distribution agreement, Fumouze Diagnostics has
agreed to hire a sales representative to sell Diamedix and Delta
Biologicals’ products in collaboration with Fumouze Diagnostics’
existing direct sales force. Diamedix and Delta Biologicals have a
combined suite of products that includes more than 200 diagnostics tests
in the areas of infectious disease, autoimmune disease and allergies.
Delta Biologicals also manufactures a line of instruments for use in
clinical and hospital laboratories.
Charles Struby, Ph.D., Chief Executive Officer and President of IVAX
Diagnostics, said, “As the international market for diagnostics
increases in importance, one of our goals for 2010 is to increase our
presence in key countries in Europe and South America. We expect that
our distribution agreement with Fumouze Diagnostics will open the French
market to Diamedix and Delta Biologicals’ suite of more than 200
diagnostic tests and will be a major step towards attaining our goal of
expanding our product reach in Europe. We believe that partnering with
Fumouze Diagnostics, a company with a well-established history of
bringing important products to market, and a reputation for outstanding
customer service, will provide us with a strong and well-established
distribution network for our expanding suite of diagnostics products.”
Source IVAX Diagnostics, Inc.